Category: News

What kind of effect does opioid use disorder medication have on opioid cravings? 

Buprenorphine with naloxone (also known as Suboxone) and methadone are two of the most widely used medications prescribed as opioid agonist therapy (OAT) to treat opioid use disorders in Canada. The aim of OAT is to replace the use of unregulated opioids with a safe and legal therapeutic medication that can prevent opioid cravings and withdrawal symptoms. This can in turn reduce the risk of overdose and other potential harms of opioid use disorder but it is not meant for everyone. In addition to these treatments, we also need greater access to safe supply, which is defined as a legal...

Read more
 

The Medicine Bundle: An Indigenous approach to HIV self-testing

In April 2022, the Two-Spirit Program at Community-Based Research Centre (CBRC) launched the pilot of the Medicine Bundle, an HIV self-testing initiative in British Columbia created by and for Two-Spirit and LGBTQ+ Indigenous folks. The pilot emerged from nearly two years of consultation and engagement with Elders, activists, researchers and community members within the Two-Spirit community, who provided guidance on culturally sensitive and intentional ways to address disparities in access to HIV testing. Following its initial run in August 2022, the Medicine Bundle has now returned to once again serve Indigenous folks wishing to access HIV self-testing. This time around,...

Read more
 

The Northern, Remote and Isolated Indigenous Communities Initiative: Community-based testing from COVID-19 to HIV and STBBI

Access to HIV and STBBI testing Laboratory testing for HIV and other sexually transmitted and blood-borne infections (STBBI) can be inaccessible to certain populations such as northern, remote and isolated Indigenous (NRI) communities. This is due to several factors, such as: Decentralized, community-owned, community-based testing (CBT) and health services help address these factors and reduce historical health inequities faced by people living in NRI communities throughout Canada. Providing a variety of innovative testing options can be particularly useful for reaching the undiagnosed by offering greater accessibility, privacy and convenience, as well as by reducing the stigma associated with accessing conventional...

Read more
 

HIV self-testing: a new tool in our toolbox

HIV self-testing has arrived in Canada! As we reported a few months ago, the Public Health Agency of Canada (PHAC) announced new funding to increase access to HIV self-testing. Since then, community-based organizations across the country have been distributing HIV self-test kits for free, as well as supporting their clients to use them. Distribution began in November 2022 and is expected to continue at least until March 2023. Together with PHAC, Communities, Alliances & Networks (CAAN), CATIE, Community-Based Research Centre (CBRC) and REACH Nexus are collaborating to support frontline workers to incorporate self-testing into their services. We are working with...

Read more

INHSU 2022: Canada’s place in the global landscape of the health of people who use drugs and hepatitis C elimination

The International Network on Health and Hepatitis in Substance Users (INHSU) hosted its first hybrid virtual and in-person conference in Glasgow, Scotland, from October 19 to 21, 2022. INHSU brings together healthcare and social service providers, researchers, people with lived and living experience, advocates, policy-makers and community leaders to discuss emerging issues, innovative programs, new research and approaches to supporting the health of people who use drugs around the world. Main conference themes included reducing harms and improving the health of people who use drugs, as well as assessing progress and possibilities related to achieving the elimination of hepatitis C...

Read more

INHSU 2022: Global perspectives on the health of people who use drugs

In October 2022, CATIE attended the 10th International Conference on Health and Hepatitis Care in Substance Users, INHSU 2022, in Glasgow, Scotland. INHSU 2022 is the leading international conference on hepatitis C and the health of people who use drugs. Researchers, frontline service providers, policy-makers, advocates and people with lived and living experience gathered from around the world to share and discuss the latest in research, programs and policy on the health of people who use drugs. We interviewed several Canadian and international attendees to share what they learned at INHSU 2022, as well as their reflections on the future...

Read more